Intein mediated high throughput screening for bispecific antibodies

• Egile Nagusiak: Tim Hofmann (Egilea), Johannes Schmidt (Egilea), Elke Ciesielski (Egilea), Stefan Becker (Egilea), Thomas Rysiok (Egilea), Mark Schütte (Egilea), Lars Toleikis (Egilea), Harald Kolmar (Egilea), Achim Doerner (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Bispecific antibodies comprise extremely diverse architectures enabling complex modes of action, such as effector cell recruitment or conditional target modulation via dual targeting, not conveyed by monospecific antibodies. In recent years, research on bispecific therapeutics has substantially grow...